In cancer therapy, functionalized peptide hydrogels can target tumors by delivering anticancer drugs or sequestering growth factors like vascular endothelial growth factor (VEGF), thereby inhibiting angiogenesis and reducing tumor invasion and metastasis [78]. This evidence concerns the gene VEGFA and neoplasm.